Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Davidson

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Cancer Research|January 13, 2001
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibitionX Yang, A T Ferguson, S J Nass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancerM J Kennedy, G B Vogelsang, R J Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 studyH A Hahm, D K Armstrong, T L Chen, et al.
Cancer Research|July 4, 1998
Mapping of ER gene CpG island methylation-specific polymerase chain reactionR G Lapidus, S J Nass, K A Butash, et al.
Journal of the National Cancer Institute|August 16, 1995
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancerR M Elledge, R Gray, E Mansour, et al.
Cancer Research|March 1, 1996
The estrogen receptor CpG island is methylated in most hematopoietic neoplasmsJ P Issa, B A Zehnbauer, C I Civin, et al.
The Journal of Biological Chemistry|May 21, 1999
Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikisT J Kottke, A L Blajeski, L M Martins, et al.
Journal of the National Cancer Institute|April 4, 1990
Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancerM D Abeloff, R A Beveridge, R C Donehower, et al.
Blood|February 15, 1995
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factorJ L Passos-Coelho, A A Ross, T J Moss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancerM J Kennedy, D K Armstrong, A M Huelskamp, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Cancer Research|January 13, 2001
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibitionX Yang, A T Ferguson, S J Nass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancerM J Kennedy, G B Vogelsang, R J Jones, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 studyH A Hahm, D K Armstrong, T L Chen, et al.
Cancer Research|July 4, 1998
Mapping of ER gene CpG island methylation-specific polymerase chain reactionR G Lapidus, S J Nass, K A Butash, et al.
Journal of the National Cancer Institute|August 16, 1995
Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancerR M Elledge, R Gray, E Mansour, et al.
Cancer Research|March 1, 1996
The estrogen receptor CpG island is methylated in most hematopoietic neoplasmsJ P Issa, B A Zehnbauer, C I Civin, et al.
The Journal of Biological Chemistry|May 21, 1999
Comparison of paclitaxel-, 5-fluoro-2'-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. Evidence for EGF-induced anoikisT J Kottke, A L Blajeski, L M Martins, et al.
Journal of the National Cancer Institute|April 4, 1990
Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancerM D Abeloff, R A Beveridge, R C Donehower, et al.
Blood|February 15, 1995
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factorJ L Passos-Coelho, A A Ross, T J Moss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancerM J Kennedy, D K Armstrong, A M Huelskamp, et al.
Pageof 13